Cargando…
Effectiveness of COVID-19 Vaccination Against SARS-CoV-2 Omicron Variant Infection and Symptoms — China, December 2022–February 2023
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? A considerable percentage of the population has received both primary and booster vaccinations, which could potentially provide protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron infections and related symptoms. WHAT IS ADD...
Autores principales: | Fu, Di, He, Guanhao, Li, Huanlong, Tan, Haomin, Ji, Xiaohui, Lin, Ziqiang, Hu, Jianxiong, Liu, Tao, Xiao, Jianpeng, Liang, Xiaofeng, Ma, Wenjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184382/ https://www.ncbi.nlm.nih.gov/pubmed/37197449 http://dx.doi.org/10.46234/ccdcw2023.070 |
Ejemplares similares
-
Association Between COVID-19 Vaccination Coverage and Case Fatality Ratio: a Comparative Study — Hong Kong SAR, China and Singapore, December 2021–March 2022
por: He, Guanhao, et al.
Publicado: (2022) -
The Infection of Healthcare Workers and the Reinfection of Patients by Omicron Variant — Jiangsu Province, China, December 2022 to January 2023
por: Zhang, Chuanmeng, et al.
Publicado: (2023) -
The Associated Factors of SARS-CoV-2 Reinfection by Omicron Variant — Guangdong Province, China, December 2022 to January 2023
por: Cai, Chunsheng, et al.
Publicado: (2023) -
Timing and Magnitude of the Second Wave of the COVID-19 Omicron Variant — 189 Countries and Territories, November 2021 to February 2023
por: Niu, Beidi, et al.
Publicado: (2023) -
Association of COVID-19 Vaccination and Clinical Severity of Patients Infected with Delta or Omicron Variants — China, May 21, 2021–February 28, 2022
por: Li, Mingshuang, et al.
Publicado: (2022)